Explore more about: Devices for Pain

The National Institutes of Health has awarded research funding for seven pilot projects developing early stage, yet groundbreaking neuro-technologies. The innovative projects would enable new medical devices to diagnose and treat both acute and chronic disorders, from neuropathic pain to mental illness.

The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system.

NIH-funded researchers at Carnegie Mellon University have demonstrated the potential of a neuromodulation approach that uses low-intensity ultrasound energy, called transcranial focused ultrasound—or tFUS.

Electrically stimulating nerves can reduce epileptic seizures, soothe chronic pain, and treat depression. Now, biomedical engineers have made a significant advance that could dramatically reduce the cost of neuromodulation therapy, increase its reliability and make it much less invasive.

Wireless microcontrollers release precise amounts of antibiotics, painkillers, growth factors or other medications. The bandage, which remains several years from market, could improve treatment of chronic skin wounds related to diabetes. Read more at Nebraska Today.